Skip to main navigation Skip to search Skip to main content

Open-Label, Single-Arm Study of the Safety and Efficacy of CC-5013 Monotherapy for Subjects with Multiple Melanoma: A Companion Study for Studies THAL-MM-003, CC-5013-MM-009 and CC-5013-MM-010

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date01/6/04 → 06/30/09

Funding

  • Celgene Corporation: $22,690.90